The Food and Drug Administration (FDA) has approved Trikafta (elexacaftor/tezacaftor/ivacaftor; Vertex) for the treatment of patients aged 12 years and older with cystic fibrosis (CF) who have ≥1 F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Trikafta is a fixed-dose combination containing elexacaftor 100mg, tezacaftor 50mg, and ivacaftor 75mg that is co-packaged…
Post-ICU syndrome includes psychological effects — depression, anxiety, and PTSD — as well as worsened physical functioning.
A task force created by the European Academy of Allergy and Clinical Immunology released recommendations and an action plan for the potential of mobile health in allergology.
A new clinical practice guideline published in the Annals of the American Thoracic Society outlines the recommendations for use of home oxygen therapy in children.
Children with nonspecific chronic cough may not need to be routinely evaluated or treated with empirical therapy for gastroesophageal reflux without overt regurgitation.
Lack of plumbing maintenance; aging infrastructure; warm, humid climates; and exposure to the immunocompromised may contribute to an increase in Legionnaires disease.
A panel of experts and organizational representatives updated the 2014 CHEST guidelines for pulmonary arterial hypertension therapy.
A shift toward personalized medicine in pneumonia management would involve refining the diagnostic categories to include viral pneumonia, bacterial pneumonia, and noninfectious respiratory disease.
VentStar and ID Breathing Circuits and Anesthesia Sets have been recalled because some of the devices may not have been correctly assembled, which may have resulted in a short circuited breathing hose.
Digital interventions, such as web-based programs, mobile apps, and text messaging, have been found to improve asthma control and medication adherence while reducing the use of “rescue” medications.
